Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment

@article{deVries2014YoungAP,
  title={Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment},
  author={Annelou L. C. de Vries and Jenifer K. McGuire and Thomas D Steensma and E. Wagenaar and Theo A. H. Doreleijers and Peggy T Cohen-Kettenis},
  journal={Pediatrics},
  year={2014},
  volume={134},
  pages={696 - 704}
}
BACKGROUND: In recent years, puberty suppression by means of gonadotropin-releasing hormone analogs has become accepted in clinical management of adolescents who have gender dysphoria (GD). The current study is the first longer-term longitudinal evaluation of the effectiveness of this approach. METHODS: A total of 55 young transgender adults (22 transwomen and 33 transmen) who had received puberty suppression during adolescence were assessed 3 times: before the start of puberty suppression… Expand
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
TLDR
Psychological support and puberty suppression were both associated with an improved global psychosocial functioning in GD adolescents, and both these interventions may be considered effective in the clinical management of psychossocial functioning difficulties inGD adolescents. Expand
Challenges in Timing Puberty Suppression for Gender-Nonconforming Adolescents
TLDR
Adolescents presenting at younger age at the time of starting medical-affirming treatment (puberty suppression or hormones) would be expected to correlate with fewer psychological difficulties related to physical changes than older individuals. Expand
Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
TLDR
The vast majority who started GnRHa proceeded to GAH, possibly due to eligibility criteria that select those highly likely to pursue further gender-affirming treatment, and it is not possible to say if GnR Ha treatment itself influenced the outcome. Expand
Puberty suppression in transgender children and adolescents.
TLDR
The available empirical evidence on the cognitive, physical, and surgical implications of puberty suppression in gender-incongruent children and adolescents is reviewed and key research priorities are proposed. Expand
Challenges in Timing Puberty Suppression for Gender-Nonconforming Adolescents
TLDR
Adolescents presenting at younger age at the time of starting medicalaffirming treatment (puberty suppression or hormones) would be expected to correlate with fewer psychological difficulties related to physical changes than older individuals, and Sorbara et al confirmed this. Expand
Gender dysphoria in children and adolescents: a review of recent research
TLDR
The first reports about long-term outcome in adolescents having undergone puberty suppression have shown promising results, and it is indicated that young people with gender dysphoria may benefit substantially with regard to psychosocial outcomes. Expand
Psychosocial health in adolescents and young adults with gender dysphoria before and after gender-affirming medical interventions: a descriptive study from the Hamburg Gender Identity Service
TLDR
How dimensions of psychosocial health were distributed among different intervention groups of adolescents with a GD diagnosis from the Hamburg Gender Identity Service before and after treatment is described to highlight the urgent need for further ongoing longitudinal research. Expand
Psychosocial assessment in transgender adolescents
TLDR
The rates of anxiety, emotional and behaviour distress, depressive symptomatology, as well as the feeling of gender dysphoria of these transgender patients were similar to those of non-transsexual population of the same age after one year of CHT initiated at ages between 14 and 18 years old. Expand
Gender incongruence and gender dysphoria in childhood and adolescence—current insights in diagnostics, management, and follow-up
TLDR
The somatic treatment generally consists of the use of GnRH analogues to prevent the progression of biological puberty and subsequently gender-affirming hormonal treatment to develop sex characteristics of the self-identified gender and surgical procedures. Expand
Understanding Pediatric Patients Who Discontinue Gender-Affirming Hormonal Interventions
TLDR
In the clinical experience, nearly all adolescents who initiate treatment with a GnRHa maintain a transgender identity and continue hormone treatment in adulthood, although occasionally, some adolescents discontinue hormones. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
INTRODUCTION Puberty suppression by means of gonadotropin-releasing hormone analogues (GnRHa) is used for young transsexuals between 12 and 16 years of age. The purpose of this intervention is toExpand
Puberty Suppression in a Gender-Dysphoric Adolescent: A 22-Year Follow-Up
TLDR
This first report on long-term effects of puberty suppression suggests that negative side effects are limited and that it can be a useful additional tool in the diagnosis and treatment of gender dysphoric adolescents. Expand
Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects
TLDR
Preliminary findings suggest that a decrease in height velocity and bone maturation occurs, and GnRHa treatment appears to be an important contribution to the clinical management of gender identity disorder in transsexual adolescents. Expand
Puberty suppression in gender identity disorder: the Amsterdam experience
TLDR
From the studies that have been published thus far, it seems that the benefits outweigh the risks, however, more systematic research in this area is needed to determine the safety of this approach. Expand
[Adolescents with gender identity disorder: reconsideration of the age limits for endocrine treatment and surgery].
  • M. Nakatsuka
  • Psychology, Medicine
  • Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
  • 2012
TLDR
It is recommended that transsexual adolescents are treated by the endocrinologists to suppress puberty with gonadotropin-releasing hormone (GnRH) agonists until age 16 years old, after which cross-sex hormones may be given. Expand
Puberty-Blocking Hormonal Therapy for Adolescents with Gender Identity Disorder: A Descriptive Clinical Study
The use of puberty-delaying or blocking hormonal treatment of adolescents with gender identity disorder (GID) has become increasingly common. In the present study, we examined demographic, behaviorExpand
Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.
TLDR
It is confirmed the reversibility of hypothalamic-pituitary-ovarian axis suppression in females after cessation of GnRHa therapy, with the majority of patients achieving ovulatory menstrual cycles of normal timing and duration. Expand
Desisting and persisting gender dysphoria after childhood: A qualitative follow-up study
TLDR
Both persisters and desisters stated that the changes in their social environment, the anticipated and actual feminization or masculinization of their bodies, and the first experiences of falling in love and sexual attraction had influenced their gender related interests and behaviour, feelings of gender discomfort and gender identification. Expand
Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study.
TLDR
Intensity of early GD appears to be an important predictor of persistence of GD, and clinical recommendations for the support of children with GD may need to be developed independently for natal boys and for girls. Expand
Treatment of adolescents with gender dysphoria in the Netherlands.
In the Netherlands, gender dysphoric adolescents may be eligible for puberty suppression at age 12, subsequent cross-sex hormone treatment at age 16, and gender reassignment surgery at age 18.Expand
...
1
2
3
4
5
...